Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Hormones Regulating Blood Glucose01:16

Hormones Regulating Blood Glucose

3.7K
Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
3.7K
Glucagon-like Receptor Agonists01:24

Glucagon-like Receptor Agonists

383
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
383
Glucose Homeostasis: Regulation of Blood Glucose01:02

Glucose Homeostasis: Regulation of Blood Glucose

2.0K
Carbohydrates consumed through foods are converted into glucose, a crucial energy source for the body. In the prandial state, high blood glucose levels stimulate the secretion of insulin from the pancreas. Insulin inhibits hepatic glucose production and stimulates glucose uptake and metabolism by muscle and adipose tissue. The excess glucose is converted into glycogen and stored in the liver and muscles.
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
2.0K
Metabolic States of the Body: Fasting and Starvation01:24

Metabolic States of the Body: Fasting and Starvation

1.7K
During the initial hours of fasting, the body uses up its glycogen stores as an energy source. Once these glycogen reserves are depleted, the body begins breaking down stored triglycerides and structural proteins. During this stage, glycerol becomes a key substrate for gluconeogenesis, while free fatty acids undergo beta-oxidation to provide energy for tissues, such as skeletal muscle. In the fasting state, the body spares protein breakdown as much as possible to conserve muscle and structural...
1.7K
Metabolic States of the Body: The Postabsorptive State01:18

Metabolic States of the Body: The Postabsorptive State

478
The postabsorptive state usually starts about four hours after a meal and lasts until the next meal is eaten. During this time, the digestive system stops absorbing nutrients, and the body uses stored energy reserves to maintain stable blood glucose levels.
Initially, glycogen stored in the liver is broken down to release glucose into the bloodstream, while glycogen in the muscles is broken down to supply glucose for energy directly within the muscle cells. As glycogen stores diminish,...
478
Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

311
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
311

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Transparent, Microfluidic Lab On A Chip For Multi-Modal Cell Culture Monitoring For Neurotoxicity Research.

IEEE transactions on nanobioscience·2026
Same author

Efficacy and safety of infigratinib in patients with refractory advanced gastric or gastroesophageal junction adenocarcinoma harboring FGFR2 gene amplification: a single-arm, multicenter phase 2 trial.

British journal of cancer·2026
Same author

Chronic Lymphocytic Leukemia: Molecular Pathologies and Therapeutic Strategies.

International journal of molecular sciences·2026
Same author

Savolitinib in MET-amplified gastric or gastroesophageal junction adenocarcinoma: a phase 2 trial.

Nature medicine·2026
Same author

Spontaneous Forniceal Rupture and Subcapsular Hematoma in a Horseshoe Kidney Managed with Transarterial Embolization: A Case Report.

Journal of vascular and interventional radiology : JVIR·2026
Same author

Phylodynamics and molecular epidemiology of the respiratory syncytial virus fusion protein in China.

Microbiology spectrum·2026
Same journal

Correction: Characterization of Mast2 kinase defines structural features, regulation, and substrates.

The Journal of biological chemistry·2026
Same journal

Isotope-Edited ESEEM: A New Method for Probing Copper Binding Sites in Neurodegenerative Proteins.

The Journal of biological chemistry·2026
Same journal

Introduction to the Thematic Review Series on Intracellular Protein Degradation. The ubiquitous biology of intracellular protein degradation: a tribute to Alfred L. ("Fred") Goldberg.

The Journal of biological chemistry·2026
Same journal

Correction: Aromatic residue-rich amino-terminal segments of temporin L self-assemble into collagen-mimetic peptides with cell-adhesion properties.

The Journal of biological chemistry·2026
Same journal

YhbO is a DJ-1 family glyoxalase and α-oxoaldehyde hydratase that confers resistance to reactive carbonyl stress (112).

The Journal of biological chemistry·2026
Same journal

ARMH3 acts as a central scaffold at the Golgi/TGN through interactions with Arl5, GBF1, and PI4KB.

The Journal of biological chemistry·2026
See all related articles

Related Experiment Video

Updated: Aug 20, 2025

Measurement of Insulin- and Contraction-Stimulated Glucose Uptake in Isolated and Incubated Mature Skeletal Muscle from Mice
08:01

Measurement of Insulin- and Contraction-Stimulated Glucose Uptake in Isolated and Incubated Mature Skeletal Muscle from Mice

Published on: May 16, 2021

5.9K

Glucagon changes substrate preference in gluconeogenesis.

Huiting Xu1, Yujue Wang2, Hyokjoon Kwon1

  • 1Department of Medicine, Rutgers-Robert Wood Johnson Medical School, New Brunswick, New Jersey, USA.

The Journal of Biological Chemistry
|November 19, 2022
PubMed
Summary
This summary is machine-generated.

Fasting hyperglycemia in diabetes is linked to glucagon. This study shows glycerol is the primary source for glucose production in liver cells, even with glucagon stimulation, highlighting its crucial role in gluconeogenesis (GNG).

Keywords:
PKAglucagongluconeogenesisglycerolliver metabolism

More Related Videos

Spectrophotometric Methods for the Study of Eukaryotic Glycogen Metabolism
07:59

Spectrophotometric Methods for the Study of Eukaryotic Glycogen Metabolism

Published on: August 19, 2021

3.8K
Glucose Uptake Measurement and Response to Insulin Stimulation in In Vitro Cultured Human Primary Myotubes
08:03

Glucose Uptake Measurement and Response to Insulin Stimulation in In Vitro Cultured Human Primary Myotubes

Published on: June 25, 2017

20.1K

Related Experiment Videos

Last Updated: Aug 20, 2025

Measurement of Insulin- and Contraction-Stimulated Glucose Uptake in Isolated and Incubated Mature Skeletal Muscle from Mice
08:01

Measurement of Insulin- and Contraction-Stimulated Glucose Uptake in Isolated and Incubated Mature Skeletal Muscle from Mice

Published on: May 16, 2021

5.9K
Spectrophotometric Methods for the Study of Eukaryotic Glycogen Metabolism
07:59

Spectrophotometric Methods for the Study of Eukaryotic Glycogen Metabolism

Published on: August 19, 2021

3.8K
Glucose Uptake Measurement and Response to Insulin Stimulation in In Vitro Cultured Human Primary Myotubes
08:03

Glucose Uptake Measurement and Response to Insulin Stimulation in In Vitro Cultured Human Primary Myotubes

Published on: June 25, 2017

20.1K

Area of Science:

  • Biochemistry
  • Metabolic Regulation
  • Diabetes Pathophysiology

Background:

  • Fasting hyperglycemia in diabetes mellitus stems from unregulated glucagon secretion, driving gluconeogenesis (GNG).
  • Previous studies on GNG substrates in hepatocytes used limited substrates and non-physiologic concentrations.
  • Understanding substrate utilization is key to managing hyperglycemia.

Purpose of the Study:

  • To investigate the relative contributions of different substrates (glycerol, pyruvate/lactate, glutamine) to glucose production in primary hepatocytes under fasting conditions.
  • To determine how glucagon stimulation affects the utilization of these substrates in gluconeogenesis.
  • To elucidate the role of glycerol as a carbon donor in hepatic gluconeogenesis.

Main Methods:

  • Cultured primary hepatocytes were treated with mixtures of U-13C- or 2-13C-labeled substrates (pyruvate/lactate, glutamine, glycerol) at fasting concentrations.
  • 13C labeling was used to trace substrate incorporation into newly synthesized glucose.
  • Metabolic flux analysis and *in vivo* studies in a PKA-activation mouse model were employed.

Main Results:

  • In the absence of glucagon, 80% of glucose produced incorporated labeled glycerol, indicating its high contribution to GNG.
  • Glucagon stimulation increased glycerol and pyruvate/lactate contributions by 1.6- and 1.8-fold, respectively, but increased glutamine's contribution significantly (6.4-fold).
  • Metabolic flux analysis confirmed glycerol as the predominant carbon source for glucose production by hepatocytes. *In vivo* studies showed lactate carbons originated from glycerol, not vice versa.

Conclusions:

  • Glycerol is a major, and often primary, carbon donor for hepatic gluconeogenesis, particularly under fasting conditions.
  • While glucagon significantly enhances glutamine's role in GNG, glycerol remains a critical substrate.
  • The complex substrate utilization in GNG suggests hepatic glucagon action involves multiple mechanisms, not a single pathway.